RNS Number : 2912G
James Halstead PLC
01 October 2024
 

 

1 October 2024

 

 

JAMES HALSTEAD PLC
(the "Company")

 

Board changes

Mr Anthony Wild will stand down as Chairman at the upcoming annual general meeting to be held on 6 December 2024. Mr Wild has been a Director of the Company for 23 years, the last seven as Chairman.  

 

Consequent to Chairman's departure, the Board proposes the following changes. Mr Mark Halstead, who has held the role of Chief Executive, will step up to the position of Executive Chairman and Mr Gordon Oliver, a Director since 1999 and current Finance Director, will succeed Mr Halstead as the Chief Executive. In addition, Mr David Drillingcourt, who joined the Board in January 2024 will assume the role of Finance Director.

 

With regard to the composition of the Board this will result in three executive directors and three non-executive directors.

 

Commenting on Anthony Wild, Mark Halstead said:

 

''On behalf of the Board I would like to express our appreciation of Anthony's contribution to the successful growth of the Company during his 23 years on the board.''

 



 

 

Enquiries:


 


James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive


Gordon Oliver, Finance Director


 


Hudson Sandler

Tel: 020 7796 4133

Nick Lyon / Nick Moore




Panmure Liberum (Nomad and Joint Broker)

Tel: 020 7886 2500

Ed Mansfield / Tom Scrivens




Zeus  (Joint Broker)        

Ben Thorne / Fraser Marshall

 

Tel: 020 3829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURUORSNUKOAR